Pulmonary Embolism International THrOmbolysis Study-3
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 800 participants.
Also called NCT04430569
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT04430569 -
2018-000816-96
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Poland, Portugal, Romania, Serbia, Slovenia, Spain, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04430569. Randomized; triple masking; primary purpose treatment. Start 2021-08-04 (actual); primary completion 2026-04-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulmonary Embolism International THrOmbolysis Study-3
- Acronym
- PEITHO-3
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Alteplase
- Intervention (Drug)
- Placebo
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Johannes Gutenberg University Mainz
- Collaborator
- Life Sciences Research Partners (D Collen Research Foundation)
- Collaborator
- Canadian Institutes of Health Research (CIHR)
- Collaborator
- Instituto de Salud Carlos III
- Collaborator
- International Network of VENous Thromboembolism Clinical Research Networks
- Collaborator
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct04430569- Content hash
097634de6c81b6a74d1cade7f7add0b1eca0a22c3dd82dd604b4ec9ef72dad79